KIMBERLY KENDALL: Open Payments
NPI 1962737288 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 8 payments from 3 companies in 2025. Trend: 2023 $177 · 2024 $198 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $304 |
| Lilly USA, LLC | 1 | $95 |
| Rhythm Pharmaceuticals, Inc. | 1 | $23 |
Products named: Wegovy, Ozempic, ZEPBOUND, IMCIVREE.
Industry payments across MI — which companies pay providers there.
